Literature DB >> 3708941

Prevention of cyclosporine (CyA) nephrotoxicity by synthetic prostaglandins.

L Makowka, W Lopatin, T Gilas, J Falk, M J Phillips, R Falk.   

Abstract

Acute and chronic nephrotoxicity directly attributable to cyclosporine (CyA) administration remains an obstacle to its successful use. The studies presented in this report characterize the cytoprotective properties of 16,16-dimethyl prostaglandin E2 in a lethal CyA-induced nephrotoxic rodent model. Wistar-Furth rats (200-250 g) receiving CyA alone (100 mg/kg/day) showed marked deterioration in renal function with severe histologic renal lesions and death of the majority of animals by day 7. The prostaglandin treated group (10/micrograms/kg/day) administered concomitantly with CyA demonstrated near normal renal function and histology by the eighth day after CyA discontinuation, and in a significant improvement in animal survival of 85% (p less than 0.001, n = at least 20 rats/group). These studies demonstrate a novel approach to a major problem with cyclosporine and should have exciting clinical potential.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3708941

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  8 in total

1.  Liver transplantation in positive cytotoxic crossmatch cases using FK506, high-dose steroids, and prostaglandin E1.

Authors:  S Takaya; Y Iwaki; T E Starzl
Journal:  Transplantation       Date:  1992-11       Impact factor: 4.939

2.  Use of prostaglandin E1 in crossmatch-negative liver transplant recipients treated with FK 506.

Authors:  S Takaya; O Bronsther; K Abu-Elmagd; H Ramos; J J Fung; S Todo; T E Starzl
Journal:  Transplant Proc       Date:  1993-06       Impact factor: 1.066

3.  The Future of Xenotransplantation.

Authors:  Thomas E Starzl
Journal:  Ann Surg       Date:  1992-10-01       Impact factor: 12.969

4.  Influence of enalapril on experimental cyclosporin A nephrotoxicity.

Authors:  A Anarat; A Noyan; G Gonlusen; N Duman; D Tuncer
Journal:  Pediatr Nephrol       Date:  1996-10       Impact factor: 3.714

Review 5.  The pathophysiology of Sandimmune (cyclosporine) in man and animals.

Authors:  J Mason
Journal:  Pediatr Nephrol       Date:  1990-09       Impact factor: 3.714

6.  Effects of cyclosporin and FK-506 on glomerular mesangial cells. Evidence for direct inhibition of thromboxane synthase by low cyclosporin concentrations.

Authors:  H H Radeke; S Kuster; V Kaever; K Resch
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 7.  Renal effects of peptic ulcer therapy.

Authors:  E Burgess; D Muruve
Journal:  Drug Saf       Date:  1992 Jul-Aug       Impact factor: 5.606

8.  Interactions between cyclosporin A, indomethacin and 16,16-dimethyl prostaglandin E2: effects on renal, hepatic and gastrointestinal toxicity in the rat.

Authors:  P H Whiting; N Barnard; A Neilsch; J G Simpson; M D Burke
Journal:  Br J Exp Pathol       Date:  1987-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.